Bank of Stockton’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $673K | Sell |
8,601
-281
| -3% | -$22.7K | 0.19% | 86 |
|
|
2026
Q1 | $770K | Buy |
8,882
+1,689
| +23% | +$162K | 0.24% | 78 |
|
|
2025
Q4 | $691K | Buy |
7,193
+196
| +3% | +$19K | 0.2% | 80 |
|
|
2025
Q3 | $666K | Buy |
6,997
+347
| +5% | +$31.9K | 0.19% | 78 |
|
|
2025
Q2 | $580K | Buy |
6,650
+150
| +2% | +$12.7K | 0.17% | 81 |
|
|
2025
Q1 | $584K | Sell |
6,500
-261
| -4% | -$23.4K | 0.19% | 78 |
|
|
2024
Q4 | $540K | Sell |
6,761
-490
| -7% | -$42.4K | 0.16% | 85 |
|
|
2024
Q3 | $653K | Buy |
7,251
+6
| +0.1% | +$505 | 0.2% | 71 |
|
|
2024
Q2 | $570K | Buy |
7,245
+30
| +0.4% | +$2.46K | 0.18% | 79 |
|
|
2024
Q1 | $629K | Sell |
7,215
-37
| -0.5% | -$3.16K | 0.19% | 74 |
|
|
2023
Q4 | $627K | Sell |
7,252
-470
| -6% | -$35.8K | 0.21% | 69 |
|
|
2023
Q3 | $543K | Buy |
7,722
+1,130
| +17% | +$94.6K | 0.2% | 72 |
|
|
2023
Q2 | $581K | Sell |
6,592
-748
| -10% | -$64.4K | 0.2% | 71 |
|
|
2023
Q1 | $592K | Sell |
7,340
-852
| -10% | -$69.4K | 0.21% | 72 |
|
|
2022
Q4 | $637K | Sell |
8,192
-593
| -7% | -$48.1K | 0.22% | 70 |
|
|
2022
Q3 | $709K | Sell |
8,785
-1,273
| -13% | -$114K | 0.27% | 61 |
|
|
2022
Q2 | $903K | Buy |
10,058
+115
| +1% | +$11.7K | 0.34% | 53 |
|
|
2022
Q1 | $1.1M | Buy |
9,943
+1,489
| +18% | +$157K | 0.34% | 53 |
|
|
2021
Q4 | $875K | Buy |
8,454
+19
| +0.2% | +$2.2K | 0.26% | 60 |
|
|
2021
Q3 | $1.06M | Sell |
8,435
-265
| -3% | -$34.3K | 0.32% | 54 |
|
|
2021
Q2 | $1.08M | Sell |
8,700
-229
| -3% | -$28.8K | 0.33% | 54 |
|
|
2021
Q1 | $1.05M | Buy |
8,929
+73
| +0.8% | +$8.56K | 0.35% | 54 |
|
|
2020
Q4 | $1.04M | Buy |
8,856
+310
| +4% | +$34.1K | 0.4% | 51 |
|
|
2020
Q3 | $888K | Sell |
8,546
-765
| -8% | -$76.8K | 0.37% | 53 |
|
|
2020
Q2 | $853K | Buy |
9,311
+1,694
| +22% | +$162K | 0.37% | 54 |
|
|
2020
Q1 | $686K | Buy |
7,617
+101
| +1% | +$10.7K | 0.38% | 49 |
|
|
2019
Q4 | $852K | Sell |
7,516
-466
| -6% | -$51.1K | 0.36% | 55 |
|
|
2019
Q3 | $867K | Buy |
7,982
+605
| +8% | +$63.1K | 0.38% | 52 |
|
|
2019
Q2 | $718K | Sell |
7,377
-320
| -4% | -$29.2K | 0.36% | 58 |
|
|
2019
Q1 | $701K | Buy |
7,697
+434
| +6% | +$38.8K | 0.36% | 59 |
|
|
2018
Q4 | $660K | Buy |
7,263
+147
| +2% | +$13.7K | 0.4% | 57 |
|
|
2018
Q3 | $700K | Buy |
7,116
+225
| +3% | +$20.8K | 0.35% | 62 |
|
|
2018
Q2 | $589K | Buy |
6,891
+1,171
| +20% | +$97.8K | 0.32% | 66 |
|
|
2018
Q1 | $458K | Buy |
5,720
+630
| +12% | +$52K | 0.19% | 74 |
|
|
2017
Q4 | $411K | Buy |
5,090
+805
| +19% | +$64.5K | 0.17% | 83 |
|
|
2017
Q3 | $333K | Buy |
4,285
+1,890
| +79% | +$157K | 0.15% | 82 |
|
|
2017
Q2 | $212K | Buy |
+2,395
| New | +$202K | 0.1% | 100 |
|
Other funds holding MDT
FWIA
GAM
Bank of Stockton's MDT Position: Q2 2026 in Review
Bank of Stockton reduced its Medtronic (MDT) stake by 3.2% in Q2 2026, selling an estimated $22.7K and leaving 8,601 shares worth $673K. The position accounts for 0.19% of the portfolio, ranked #86.
Bank of Stockton first reported a position in MDT in Q2 2017 and has held it in 37 quarters since. The position peaked at $1.1M in Q1 2022. 1,052 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Bank of Stockton held 8,601 shares of Medtronic worth $673K as of Q2 2026.
- Bank of Stockton sold 281 Medtronic shares in Q2 2026, an estimated $22.7K.
- Medtronic made up 0.19% of Bank of Stockton's portfolio in Q2 2026, its #86 holding.
- Bank of Stockton first reported a position in Medtronic in Q2 2017 and has held it in 37 quarters since.
- Bank of Stockton's Medtronic position peaked at $1.1M in Q1 2022.
- 1,052 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Bank of Stockton's 13F filing for Q2 2026, filed 29 Jul 2026.